StockData
Estrella Immunopharma, Inc. logo

Estrella Immunopharma, Inc. (ESLA) stock

ESLANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as ESLAW
Financials through Q1 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.33−0.05 (-12.74%)

Close on Nov 17, 2026Market cap $14.42MP/E –Yield –

Estrella Immunopharma cash

Cash and short-term investments held at the end of each period.

Estrella Immunopharma's cash was $100.00K at Jun 30, 2026. For fiscal 2024 it was $4.17M, up 769.8% from the year before.

Annual cash

PeriodPeriod endValueChange
FY2024Jun 30, 2024$4.17M+769.8%
FY2021Dec 31, 2021$478.87K–

Quarterly cash

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2026CQ3 2025Jun 30, 2026$100.00K-99.5%
Q4 FY2024CQ2 2024Jun 30, 2024$4.17M+769.8%
Q3 FY2024CQ1 2024Mar 31, 2024$4.73M+512.2%
Q2 FY2024CQ4 2023Dec 31, 2023$9.05M+82002.2%
Q1 FY2024CQ3 2023Sep 30, 2023$22.14M+52513.1%
Q4 FY2021CQ4 2021Dec 31, 2021$478.87K–
Q3 FY2021CQ3 2021Sep 30, 2021$772.17K–
Q2 FY2021CQ2 2021Jun 30, 2021$11.02K–
Q1 FY2021CQ1 2021Mar 31, 2021$42.08K–

More Estrella Immunopharma figures

See a number that looks wrong?